The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/792774
CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 52 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production SERVICES & CAPABILITIES: controlled sub- stances, cytotoxic & high potency compounds, generics, branded APIs, custom development & manufacture "I am extremely proud that Cambrex has for the third consecutive year been selected as a winner of the CMO Leadership Awards. Cambrex has a strong customer focus and a commitment to world class quality. Receiving the awards in the key categories demonstrates our continued com- mitment to our customers and recognition by the pharmaceutical industry." DRUG TYPE: Pharmaceuticals STEVEN M. KLOSK President & CEO CATEGORIES WON: Cambrex East Rutherford, NJ www.cambrex.com Phone: +1 201 804 3000 Contact: Alex Maw Email: alex.maw@cambrex.com Key locations: Charles City, IA, USA; High Point, NC, USA; Karlskoga, Sweden; Paullo, Milan, Italy; Tallinn, Estonia; Wiesbaden, Germany INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: capsules, controlled substances, cytotoxic & high potency compounds, generics, liquids, OTC, peptides, powders: non- sterile, proteins, semisolids, soft gels, solid dose, solutions & suspensions, sustained release, vac- cines "Capsugel is greatly appreciative of this recogni- tion by our customers. Our colleagues through- out the organization strive to provide integrated solutions to advance products from design and development through to commercial manufacture. Our focus is on creating novel, high-quality and customized solutions that align with our custom- ers' evolving needs. We believe our unique com- bination of science, engineering, formulation, and capsule expertise is what sets us apart." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals GUIDO DRIESEN President & CEO CATEGORIES WON: Capsugel Morristown, NJ www.capsugel.com Phone: +1 862 242 1700 Email: dfsinquiry@capsugel.com Key locations: USA, Mexico, Scotland, France, Belgium, India, China, Japan, Indonesia INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, on-time "For the fourth year in a row, Life Science Leader magazine has awarded CEPiA-Sanofi as a worldwide CMO Leader. CEPiA with its industrial European culture has strong assets: 11 chemical sites, manufacturing 200+ API, for more than 60 years. CEPiA serves all pharmaceutical compa- nies, including commercial capacities and specific molecules with exclusive agreements, promoting its Quality and Regulatory worldwide expertise." JACQUES TAVERNIER Vice President CATEGORIES WON: CEPiA Sanofi Antony, France www.cepia-sanofi.com Phone: + 33 1 41 24 55 39 Contact: Christina Da Cunha Email: christina.da-cunha@sanofi.com Key locations: Elbeuf, Sisteron, Frankfurt, Ujpest, Vertolaye, Aramon INDIVIDUAL ATTRIBUTE AWARDS: cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science DRUG TYPE: Pharmaceuticals, Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 3) Drug Substance Production: Drug Substance Production Formulated Drug Production: Dosage Form Production, Packaging SERVICES & CAPABILITIES: aseptic fill/finish, capsules, cartridges, creams & ointments, cyto- toxic & high potency compounds, gels, generics, injectables, lyophilized products, non-sterile, oph- thalmics, OTC, parenterals: large volume, parenter- als: small volume, peptides, powders (non-sterile), proteins, semisolids, solid dose, sterile, sustained release, syringes: prefilled, topicals, vaccines